Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system

References

• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–656.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471–478.
   PubMed Web of Science ®Google Scholar
• Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int. 2013;2013:284873.
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42.
   PubMed Web of Science ®Google Scholar
• Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–228.
   PubMedGoogle Scholar
• Sun Y, Feng Y, Zhang CQ, et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010;34(4):589–597.
   PubMed Web of Science ®Google Scholar
• Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 42(1): 35–41. 2014. .
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage. 21(11): 1627–1637. 2013. .
   PubMed Web of Science ®Google Scholar
• Rutjes AW, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180–191.
   PubMed Web of Science ®Google Scholar
• Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135–2140.
   PubMed Web of Science ®Google Scholar
• Cerza F, Carnì S, Carcangiu a, et al. Comparison Between Hyaluronic Acid and Platelet-Rich Plasma, Intra-articular Infiltration in the Treatment of Gonarthrosis. Am J Sports Med. 40(12): 2822–2827. 2012. .
   PubMed Web of Science ®Google Scholar
• Sánchez M, Fiz N, Azofra J, et al. a randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 28(8): 1070–1078. 2012. .
   PubMed Web of Science ®Google Scholar
• Campbell KA, Saltzman BM, Mascarenhas R, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 31(11): 2213–2221. 2015. .
   PubMed Web of Science ®Google Scholar
• Dold AP, Zywiel MG, Taylor DW, et al. Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin J Sport Med. 2014;24(1):31–43.
   PubMed Web of Science ®Google Scholar
• Hepper CT, Halvorson JJ, Duncan ST, et al. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg. 2009;17(10):638–646.
   PubMed Web of Science ®Google Scholar
• Trigkilidas D, Anand a. The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain. Ann R Coll Surg Engl. 2013;95(8):545–551.
   PubMed Web of Science ®Google Scholar
• Khoshbin a, Leroux T, Wasserstein D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29(12):2037–2048.
   PubMed Web of Science ®Google Scholar
• Chang KV, Hung CY, Aliwarga F, et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014;95(3):562–575.
   PubMed Web of Science ®Google Scholar
• Laudy AB, Bakker EW, Rekers M, et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015;49(10):657–672.
   PubMed Web of Science ®Google Scholar
• Sadabad HN, Behzadifar M, Arasteh F, et al. Efficacy of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: a systematic review and meta-analysis. Electron Physician. 2016;8(3):2115–2122.
   PubMedGoogle Scholar
• Kanchanatawan W, Arirachakaran a, Chaijenkij K, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016;24(5):1665–1677.
   PubMed Web of Science ®Google Scholar
• Xu Z, Luo J, Huang X, et al. Efficacy of platelet-rich plasma in pain and self-report function in knee osteoarthritis: a best-evidence synthesis. Am J Phys Med Rehabil. 2017;96(11):793–800.
   PubMed Web of Science ®Google Scholar
• Dai W-L, Zhou a-G, Zhang H, et al. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659–670.e1.
   PubMed Web of Science ®Google Scholar
• Shen L, Yuan T, Chen S, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16.
   PubMedGoogle Scholar
• Zhang HF, Wang CG, Li H, et al. Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis. Drug Des Devel Ther. 2018;12:445–453.
   PubMed Web of Science ®Google Scholar
• Han Y, Huang H, Pan J, et al. Meta-analysis Comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis. Pain Med. 2019;20(7):1418–1429.
   PubMed Web of Science ®Google Scholar
• Hohmann E, Tetsworth K, Glatt V. Is platelet-rich plasma effective for the treatment of knee osteoarthritis? a systematic review and meta-analysis of level 1 and 2 randomized controlled trials. Eur J Orthop Surg Traumatol. 13 14 Feb 2020;doi:10.1007/s00590-020-02623-4
   Google Scholar
• Wu Q, Luo X, Xiong Y, et al. Platelet-rich plasma versus hyaluronic acid in knee osteoarthritis: a meta-analysis with the consistent ratio of injection. J Orthop Surg (Hong Kong). 2020;28(1):2309499019887660.
   Google Scholar
• Rodeo S. The need for minimum reporting standards for studies of “biologics” in sports medicine. Am J Sports Med. 2019;47(11):2531–2532.
   PubMed Web of Science ®Google Scholar
• Vannini F, Di Matteo B, Filardo G. Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: a systematic review. J Exp Orthop. 2015;2(1):2.
   PubMedGoogle Scholar
• Giusti I, D’Ascenzo S, Mancò a, et al. Platelet concentration in platelet-rich plasma affects Tenocyte behavior in vitro. Biomed Res Int. 2014;2014:630870.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yin W, Zhang Y, et al. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration. Sci Rep. 2017;7:43301.
   PubMed Web of Science ®Google Scholar
• Kreuz PC, Krüger JP, Metzlaff S, et al. Platelet-Rich Plasma Preparation Types Show Impact on Chondrogenic Differentiation, Migration, and Proliferation of Human Subchondral Mesenchymal Progenitor Cells. Arthroscopy. 2015;31(10):1951–1961.
   PubMed Web of Science ®Google Scholar
• Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017;99(20):1769–1779.
   PubMed Web of Science ®Google Scholar
• Rossi LA, Murray IR, Chu CR, et al. Classification systems for platelet-rich plasma. Bone Joint J. 2019;101(–B(8)):891–896.
   PubMedGoogle Scholar
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–167.
   PubMed Web of Science ®Google Scholar
• Mishra a, Harmon K, Woodall J, et al. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–1195.
   PubMed Web of Science ®Google Scholar
• DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009.
   PubMed Web of Science ®Google Scholar
• Mautner K, Malanga GA, Smith J, et al. a call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PMR. 2015;7(4 Suppl):S53–S59.
   PubMedGoogle Scholar
• Magalon J, Chateau AL, Bertrand B, et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med. 2016;2(1):e000060.
   PubMedGoogle Scholar
• Lana JFSD, Purita J, Paulus C, et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen Med. 2017;12(5):565–574.
   PubMed Web of Science ®Google Scholar
• Everts PA, Malanga GA, Paul RV, et al. Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies a review. Regen Ther. 2019;11:56–64.
   PubMed Web of Science ®Google Scholar
• Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266–271.
   PubMed Web of Science ®Google Scholar
• Yin W, Xu Z, Sheng J, et al. Erythrocyte sedimentation rate and fibrinogen concentration of whole blood influences the cellular composition of platelet-rich plasma obtained from centrifugation methods. Exp Ther Med. 2017;14(3):1909–1918.
   PubMed Web of Science ®Google Scholar
• Oneto P, Zubiry PR, Schattner M, et al. Anticoagulants interfere with the angiogenic and regenerative responses mediated by platelets. Front Bioeng Biotechnol. 2020;8:223.
   PubMed Web of Science ®Google Scholar
• Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet Physiology. Semin Thromb Hemost. 2016;42(3):191–204.
   PubMed Web of Science ®Google Scholar
• Mariani E, Filardo G, Canella V, et al. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014;16(9):1294–1304.
   PubMed Web of Science ®Google Scholar
• Mariani E, Canella V, Berlingeri a, et al. Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro. BMC Microbiol. 2015;15:149.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Roffi a, et al. Platelet-rich plasma: why intra-articular? a systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2459–2474.
   PubMed Web of Science ®Google Scholar
• Di Matteo B, Loibl M, Andriolo L, et al. Biologic agents for anterior cruciate ligament healing: a systematic review. World J Orthop. 2016;7(9):592–603.
   PubMed Web of Science ®Google Scholar
• Andriolo L, Di Matteo B, Kon E, et al. PRP Augmentation for ACL Reconstruction. Biomed Res Int. 2015;2015:371746.
   PubMed Web of Science ®Google Scholar
• Perdisa F, Filardo G, Di Matteo B, et al. Platelet rich plasma: a valid augmentation for cartilage scaffolds? a systematic review. Histol Histopathol. 2014;29(7):805–814.
   PubMed Web of Science ®Google Scholar
• Guenoun D, Magalon J, de Torquemada I, et al. Treatment of degenerative meniscal tear with intrameniscal injection of platelets rich plasma. Diagn Interv Imaging. 2020;101(3):169–176.
   PubMed Web of Science ®Google Scholar
• Di Matteo B, Kon E. Editorial Commentary: biologic Products for Cartilage Regeneration-Time to Redefine the Rules of the Game? Arthroscopy. 2019;35(1):260–261.
   PubMed Web of Science ®Google Scholar
• Pagani S, Borsari V, Veronesi F, et al. Increased chondrogenic potential of mesenchymal cells from adipose tissue versus bone marrow-derived cells in osteoarthritic in vitro models. J Cell Physiol. 2017;232(6):1478–1488.
   PubMed Web of Science ®Google Scholar
• Chen PC, Wu KT, Chou WY, et al. Comparative effectiveness of different nonsurgical treatments for patellar tendinopathy: a systematic review and network meta-analysis. Arthroscopy. 2019;35(11):3117–3131.e2.
   PubMed Web of Science ®Google Scholar
• Hadley CJ, Shi WJ, Murphy H, et al. The clinical evidence behind biologic therapies promoted at annual orthopaedic meetings: a systematic review. Arthroscopy. 2019;35(1):251–259.
   PubMed Web of Science ®Google Scholar
• Di Matteo B, Filardo G, Lo Presti M, et al. Chronic anti-platelet therapy: a contraindication for platelet-rich plasma intra-articular injections? Eur Rev Med Pharmacol Sci. 2014;18(1 Suppl):55–59.
   PubMedGoogle Scholar
• Velier M, Magalon J, Daumas a, et al. Production of platelet-rich plasma gel from elderly patients under antithrombotic drugs: perspectives in chronic wounds care. Platelets. 2018;29(5):496–503.
   PubMed Web of Science ®Google Scholar
• Ozer K, Kankaya Y, Çolak Ö. An important and overlooked parameter in platelet rich plasma preparation: the mean platelet volume. J Cosmet Dermatol. 2019;18(2):474–482.
   PubMed Web of Science ®Google Scholar
• Chellini F, Tani a, Zecchi-Orlandini S, et al. Influence of platelet-rich and platelet-poor plasma on endogenous mechanisms of skeletal muscle repair/regeneration. Int J Mol Sci. 2019;20(3):3.
   Web of Science ®Google Scholar
• Sánchez M, Delgado D, Pompei O, et al. Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma: an observational study. Cartilage. 2019;10(2):245–253.
   PubMed Web of Science ®Google Scholar
• Braun HJ, Kim HJ, Chu CR, et al. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014;42(5):1204–1210.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082–2091.
   PubMed Web of Science ®Google Scholar
• Mariani E, Canella V, Cattini L, et al. Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee. PLoS One. 2016;11(6):e0156137.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Di Matteo B, et al. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2014;1(3):112–120.
   PubMedGoogle Scholar
• Kon E, Engebretsen L, Verdonk P, et al. Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial. Am J Sports Med. 2018;46(1):171–180.
   PubMed Web of Science ®Google Scholar
• Manferdini C, Paolella F, Gabusi E, et al. Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthritis Cartilage. 2017;25(7):1161–1171.
   PubMed Web of Science ®Google Scholar
• Vasina EM, Cauwenberghs S, Feijge MA, et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis. 2011;2:e211.
   PubMed Web of Science ®Google Scholar
• Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kB inhibition via HGF. J Cell Physiol. 2010;225(3):757e766.
   Web of Science ®Google Scholar
• Jansen NW, Roosendaal G, Bijlsma JW, et al. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum. 2007;56(1):199–207.
   PubMedGoogle Scholar
• Hooiveld M, Roosendaal G, Wenting M, et al. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol. 2003;162(3):943–951.
   PubMed Web of Science ®Google Scholar
• Roffi a, Filardo G, Assirelli E, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int. 2014;2014:692913.
   PubMed Web of Science ®Google Scholar
• Cavallo C, Roffi a, Grigolo B, et al. Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed Res Int. 2016;2016:6591717.
   PubMed Web of Science ®Google Scholar
• Previtali D, Merli G, Di Laura Frattura G, et al. The long-lasting effects of “placebo injections” in knee osteoarthritis: a meta-analysis. Cartilage. 2020 Mar 18;12. doi:10.1177/1947603520906597
   Google Scholar
• Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):528–535.
   PubMed Web of Science ®Google Scholar
• Altamura SA, Di Martino a, Andriolo L, et al. Platelet-rich plasma for sport-active patients with knee osteoarthritis: limited return to sport. Biomed Res Int. 2020;2020:8243865.
   PubMed Web of Science ®Google Scholar
• Di Martino a, Di Matteo B, Papio T, et al. Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med. 2019;47(2):347–354.
   PubMed Web of Science ®Google Scholar
• Acuña AJ, Samuel LT, Jeong SH, et al. Viscosupplementation for hip osteoarthritis: does systematic review of patient-reported outcome measures support use? J Orthop. 2020;21:137–149.
   PubMed Web of Science ®Google Scholar
• Vincent P. Intra-articular hyaluronic acid in the symptomatic treatment of knee osteoarthritis: a meta-analysis of single-injection products. Curr Ther Res Clin Exp. 2019;90:39–51.
   PubMed Web of Science ®Google Scholar
• Bendich I, Rubenstein WJ, Cole BJ, et al. What is the appropriate price for prp injections for knee osteoarthritis? A cost-effectiveness analysis based on evidence from level 1 randomized controlled trials. Arthroscopy. 2020 Feb 13;36(21):1983–1991.e1.
   PubMedGoogle Scholar
• Khatab S, van Buul GM, Kops N, et al. Intra-articular injections of platelet-rich plasma releasate reduce pain and synovial inflammation in a mouse model of osteoarthritis. Am J Sports Med. 2018;46(4):977–986.
   PubMed Web of Science ®Google Scholar
• Vitale ND, Vandenbulcke F, Chisari E, et al. Innovative regenerative medicine in the management of knee OA: the role of Autologous Protein Solution. J Clin Orthop Trauma. 2019;10(1):49–52.
   PubMedGoogle Scholar
• O’Shaughnessey K, Matuska a, Hoeppner J, et al. Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res. 2014;32(10):1349–1355.
   PubMed Web of Science ®Google Scholar
• Louis ML, Magalon J, Jouve E, et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34(5):1530–1540.e2.
   PubMed Web of Science ®Google Scholar
• De Santis M, Di Matteo B, Chisari E, et al. The role of wnt pathway in the pathogenesis of oa and its potential therapeutic implications in the field of regenerative medicine. Biomed Res Int. 2018;2018:7402947.
   PubMed Web of Science ®Google Scholar
• Geyer M, Schönfeld C. Novel insights into the pathogenesis of osteoarthritis. Curr Rheumatol Rev. 2018;14(2):98–107.
   PubMed Web of Science ®Google Scholar